Pfizer Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 9
Professionals
  • Investments
  • 149
  • Portfolio
  • 51
  • Exits
  • 68
Exits

Pfizer Ventures General Information

Description

Founded in 2004, Pfizer Ventures is a venture capital firm based in New York, New York. The firm is a corporate venture capital arm of Pfizer Inc that seeks to invest in companies based in the United States operating in the healthcare sector.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
+1 (212) 000-0000

Pfizer Ventures Investments (149)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Palleon Pharmaceuticals 16-Sep-2020 Later Stage VC 00000 Drug Discovery Pre-Clinical Trials 0000000 0000000
0000000 0000000000 15-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000000 00000 00.0
0000000 0000000000 06-Jul-2020 00000 00000 0000 Drug Discovery Generating Revenue 00000 0000000 00.0
0000 0000000000000 01-Jul-2020 00000 00000 000.00 Drug Discovery Generating Revenue
000000 00000000000 25-Jun-2020 00000 00000 0000 Pharmaceuticals Startup
00000000 000000000 24-Jun-2020 00000 00000 000.00 Drug Discovery Generating Revenue
0000 16-Jun-2020 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable 0000000 0000000
0000000 10-Jun-2020 00000 00000 000.00 Drug Discovery Generating Revenue
Autobahn Therapeutics 09-Jun-2020 Early Stage VC 000.00 Biotechnology Product In Beta Test
FoRx Therapeutics 22-Apr-2020 Seed Round 000.00 Drug Discovery Startup 00000 0000000 00.0
You’re viewing 10 of 149 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer Ventures Exits (68)

Company Name Exit Date Exit Type Exit Size
NeuMoDx Molecular 17-Sep-2020 Merger/Acquisition 00000
000000 00000000000 21-Aug-2020 000 00000
00000 12-Mar-2020 000 000.00
00000000000 000000 13-Sep-2019 000 00000
000000000 01-Jul-2019 000000000000000000 00000
0000000 0000000000 27-Jun-2019 000 0000
000000000 09-May-2019 000 0000
00000000 09-May-2019 000 0000
Neuronetics 28-Jun-2018 IPO 000.00
Translate Bio 28-Jun-2018 IPO 00000
You’re viewing 10 of 68 exits. Get the full list »

Pfizer Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Pfizer Ventures Team (11)

Name Title Deals Funds Boards Office
Denis Patrick Ph.D Managing Partner & Vice President, WRDM 0 0 New York, NY
Barbara Dalton Ph.D Vice President, WWBD & Senior Managing Partner 00 0 0 New York, NY
William Burkoth Senior Partner & Executive Director, WWBD 00 00 New York, NY
Christopher O'Donnell Ph.D Partner & Executive Director, WRDM 0 0 New York, NY
Michael Baran Ph.D Partner & Executive Director, WRDM 0 0 New York, NY
You’re viewing 5 of 11 team members. Get the full list »

Pfizer Ventures Co-Investors (236)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 15 0 00 Series chart Industry bar
AbbVie Ventures 0 0 Series chart Industry bar
SR One 0 00 Series chart Industry bar
WuXi AppTec 0 0 Series chart Industry bar
HBM Healthcare Investments 0 0 0 Series chart Industry bar
You’re viewing 5 of 236 co-investors. Get the full list »